KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fulgent Genetics (FLGT) Non-Current Deferred Tax Liability (2016 - 2025)

Historic Non-Current Deferred Tax Liability for Fulgent Genetics (FLGT) over the last 5 years, with Q3 2025 value amounting to $7.0 million.

  • Fulgent Genetics' Non-Current Deferred Tax Liability rose 454.41% to $7.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $7.0 million, marking a year-over-year increase of 454.41%. This contributed to the annual value of $6.4 million for FY2024, which is 1999.5% down from last year.
  • Per Fulgent Genetics' latest filing, its Non-Current Deferred Tax Liability stood at $7.0 million for Q3 2025, which was up 454.41% from $6.1 million recorded in Q2 2025.
  • In the past 5 years, Fulgent Genetics' Non-Current Deferred Tax Liability registered a high of $9.8 million during Q3 2023, and its lowest value of $6.1 million during Q2 2025.
  • Its 3-year average for Non-Current Deferred Tax Liability is $7.2 million, with a median of $6.9 million in 2024.
  • Its Non-Current Deferred Tax Liability has fluctuated over the past 5 years, first plummeted by 3151.63% in 2024, then skyrocketed by 454.41% in 2025.
  • Quarter analysis of 3 years shows Fulgent Genetics' Non-Current Deferred Tax Liability stood at $8.0 million in 2023, then dropped by 19.99% to $6.4 million in 2024, then rose by 10.52% to $7.0 million in 2025.
  • Its Non-Current Deferred Tax Liability was $7.0 million in Q3 2025, compared to $6.1 million in Q2 2025 and $6.2 million in Q1 2025.